TYB
Report 73: Pfizer Knew by November 2020 That Its mRNA COVID Vaccine Was Neither Safe Nor Effective. Here Is What Pfizerās Employees and Contractors Knew and When They Knew It.
May 31, 2023
Introduction
Through the review of two documents ā Pharmacovigilance Plan for Biologic License Application #125742 Of Covid-19 mRNA vaccine (nucleoside modified) (BNT162b2, PF-07302048) and 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021 ā referred to below as āPVā and ā5.3.6,ā the contributors to this report came to understand Pfizer knows its product does not work and that it poses a danger to the public. In this report, they have demonstrated these admissions using Pfizerās own words. When those documents are overlaid with the Emergency Use Authorization (EUA) from 2020 and the EUA from late 2021, it becomes apparent that the Company ignored safety signals and used weak statistics to justify product use. When these documents are viewed together, there is sufficient evidence to say Pfizer understood that there were problems with its mRNA COVID product before the original EUA was submitted in November 2020.
Abbreviations
PV = Pharmacovigilance Plan for Biologic License Application #125742 Of Covid-19 mRNA vaccine (nucleoside modified) (BNT162b2, PF-07302048). Date of Report: 28 July 2021, Version 1.1
EUA 2020 = Emergency Use Authorization (EUA) for an Unapproved Product Review Memorandum. Date of Document: 20 November 2020, Author: Marion F. Gruber, Ph.D., Director, CBER/OVRR
5.3.6 = Reissue of 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021. Approval Date: 30 April 2021.
EUA 5-11 = Emergency Use Authorization (EUA) for an Unapproved Product Review Memorandum. Date of Document: 06 October 2021, Author: Peter Marks, M.D., Ph. D., Director, CBER, and Acting Director, CBER/OVRR.
SOC = System Organ Class
AE = Adverse Event
1/2
Executive Summary in chronological order:
-
In November 2020 (EUA 2020), Pfizer dismissed safety signals in its clinical trial C4591001 (ages 16+). Moreover, although Pfizer considered any adverse event (AE) within six weeks of product use to be reasonably associated with the product (EUA 2020, p. 10), it dismissed the observed safety signals in EUA 2020, 5.3.6, PV, and EUA 5-11.
-
In November 2020 (EUA 2020), Pfizer had a weak demonstration of efficacy based on very few occurrences (eight cases versus 162 cases). C4591001 was essentially invalid because investigators failed to confirm or deny 3,410 suspected COVID cases (1,594 vaccinated and 1,816 placebo). If COVID occurred in the thousands and investigators used only 170 cases for efficacy, their statistics did not reflect reality. Investigators then destroyed their clinical trial by unblinding and vaccinating all placebo cohort participants (PV, p. 13, pp. 18-19). In effect, this act terminated the trial. Pfizer acknowledged unblinding and vaccinating the placebo cohort would adversely affect the data (EUA 2020, p. 53). The company cut off data collection the day after placebo participants were vaccinated (EUA 5-11, p. 12).
-
Through December 2020 to February 2021 (5.3.6) field reports, Pfizer observed AEs including deaths and permanent harms. Per Pfizerās own standard of AEs within six weeks of product use being considered product-related (EUA 2020, p. 10), Pfizer de facto recognized its product caused AEs, because many of the AEs in 5.3.6 occurred within hours or days of product use.
-
In its report dated July 28, 2021 (PV), Pfizer still planned to use C4591001 (a portion of which was due April 2023) to reach final conclusions on its mRNA COVID productās efficacy and safety. The cut off of data collection on March 12, 2021, should be understood as Pfizerās acknowledgement of the termination of its clinical trial. Pfizer attempted to substitute titer-based lab tests for efficacy, but later admitted lab titers do not represent disease protection (i.e., efficacy) (EUA 5-11, p. 13).
-
In Pfizerās July 2021 report (PV), Pfizer acknowledged pericarditis and myocarditis as risks of product use. Pfizer did not call it a dose-response, but it reported pericarditis and myocarditis risks as higher after dose #2 (PV, p. 50). Pfizer reported a similar dose-dependent pattern elsewhere (EUA 2020, p. 6, p. 42, p. 56; EUA 5-11, p. 46). All other AEs noted in the EUA 2020, from study C4591001, and AEs reported from the field in 5.3.6 were ignored. Additional studies listed by Pfizer in PV seem to not exist online.
-
In October 2021 (EUA 5-11), efficacy was weakly demonstrated. Investigators did not draw upon C4591001 for support. Rather, they substituted titers for efficacy.
-
In Pfizerās October 2021 EUA 5-11 submission, Pfizer described a dose-response relationship between its product and AEs in both dosage and dose number. Investigators speculated that subclinical damages would manifest in the long-term. The implication is that continued doses with subclinical damages would eventually manifest as clinical damages. Pfizer admitted a young male subjectās AE, previously dismissed, was actually related to product use months after initial signal detection. This event represented a pattern of behavior: no matter what AE occurred, investigators concluded it was unrelated to Pfizerās product.
-
EUA 5-11 introduced unsupported points to push product use in children. Pfizer introduced claims on transmission prevention and attacked the unvaccinated. Investigators did not provide clinical trial evidence for support. The product did not have well-demonstrated benefits, so any risks (and there are many) immediately rendered a poor risk-benefit ratio.
https://truthsocial.com/@realSidneyPowell/posts/110471673232585291
https://dailyclout.io/report-73-pfizer-knew-what-pfizers-employees-and-contractors-knew-and-when-they-knew-it/
2/2
Sidney Powell - Defending The Republic Newsletter
June 2, 2023
Good News Friday: 06/02/23
Dear Patriots,
How is it that a short week can be so darn tough?
Go forward into a summer weekend with some good news.
SPECIAL NOTE:
In our continuing battle against the lawfare launched against us for representing electors exercising their First Amendment right to petition the government by filing lawsuits after the 2020 election, Sidney argued in the Seventh Circuit in Chicago Wednesday.
You may listen to the entire argument HERE - https://defendingtherepublic.org/oral-argument-by-sidney-powell-in-feehan-v-evers-7th-circuit-court-of-appeals/
Governor Evers of WI is still trying to have Sidney and co-counsel sanctioned to stop other lawyers from ever raising the machine fraud issues again.
1- Protecting children from social media and bad mental health results is a fight worth having. We hope to see more schools hold these companies accountable.
Daily Wire
Tennessee School District Sues Social Media Companies Over Growing Mental Health Crisis Among Students
2- It gets little coverage but parents all over the country are stepping in to shield their children from the onslaught of grooming at school.
Daily Wire
Six Maryland Parents Sue School Board For Forcing Kids To Read āPrideā Books
3- At least we will not have to be held hostage to this perverted content. Donāt you love that they ended this agreement in SECRET?
NY Post
BLM leader Patrisse Cullors secretly dumped from Warner Bros TV deal
4- Alabama Governor Kay Ivey protects womenās sports from men participation.
Office of the Governor of Alabama
Governor Ivey Takes Another Step to Protect Womenās Sports, Signs House Bill 261
5- Insanity stoppedā¦. at least temporarily.
Newsmax
Pentagon Orders Air Force Base to Cancel Drag Show
6- Update on Yulia Hicks and her transplant surgery. She is doing well!
DailyWire
Mother Speaks Out After Yulia Hicks Undergoes Kidney Transplant Despite Alleged Duke Rejection Over COVID Vax
7- Do not relent. Keep up the pressure on all the boycotts.
John Nolte at Brietbart
May Ratings Collapse ā Fox Loses Third of Viewers Without Tucker Carlson
https://truthsocial.com/@realSidneyPowell/posts/110474744209797012
https://defendingtherepublic.org/good-news-friday-06-02-23/